RT Journal Article
T1 Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference.
A1 Lobitz, Stephan
A1 Telfer, Paul
A1 Cela, Elena
A1 Allaf, Bichr
A1 Angastiniotis, Michael
A1 Backman Johansson, Carolina
A1 Badens, Catherine
A1 Bento, Celeste
A1 Bouva, Marelle J
A1 Canatan, Duran
A1 Charlton, Matthew
A1 Coppinger, Cathy
A1 Daniel, Yvonne
A1 de Montalembert, Marianne
A1 Ducoroy, Patrick
A1 Dulin, Elena
A1 Fingerhut, Ralph
A1 Frömmel, Claudia
A1 García-Morin, Marina
A1 Gulbis, Béatrice
A1 Holtkamp, Ute
A1 Inusa, Baba
A1 James, John
A1 Kleanthous, Marina
A1 Klein, Jeannette
A1 Kunz, Joachim B
A1 Langabeer, Lisa
A1 Lapouméroulie, Claudine
A1 Marcao, Ana
A1 Marín Soria, José L
A1 McMahon, Corrina
A1 Ohene-Frempong, Kwaku
A1 Périni, Jean-Marc
A1 Piel, Frédéric B
A1 Russo, Giovanna
A1 Sainati, Laura
A1 Schmugge, Markus
A1 Streetly, Allison
A1 Tshilolo, Leon
A1 Turner, Charles
A1 Venturelli, Donatella
A1 Vilarinho, Laura
A1 Yahyaoui, Rachel
A1 Elion, Jacques
A1 Colombatti, Raffaella
A1 with the endorsement of EuroBloodNet, the European Reference Network in Rare Haematological Diseases
K1 haemoglobinopathies
K1 newborn screening
K1 prevention
K1 sickle cell anaemia
K1 sickle cell disease
AB Sickle Cell Disease (SCD) is an increasing global health problem and presents significant challenges to European health care systems. Newborn screening (NBS) for SCD enables early initiation of preventive measures and has contributed to a reduction in childhood mortality from SCD. Policies and methodologies for NBS vary in different countries, and this might have consequences for the quality of care and clinical outcomes for SCD across Europe. A two-day Pan-European consensus conference was held in Berlin in April 2017 in order to appraise the current status of NBS for SCD and to develop consensus-based statements on indications and methodology for NBS for SCD in Europe. More than 50 SCD experts from 13 European countries participated in the conference. This paper aims to summarise the discussions and present consensus recommendations which can be used to support the development of NBS programmes in European countries where they do not yet exist, and to review existing programmes.
YR 2018
FD 2018-10-18
LK http://hdl.handle.net/10668/13099
UL http://hdl.handle.net/10668/13099
LA en
DS RISalud
RD Apr 12, 2025